FTSE All-Share
|
5 775,83
|
-13,65
|
-0,24 %
|
Analysen zu FTSE All-Share-Werten
| 21.09.26 | Diageo Buy | Jefferies & Company Inc. | |
| 18.09.26 | BAT Buy | Deutsche Bank AG | |
| 18.09.26 | GSK Hold | Deutsche Bank AG | |
| 18.09.26 | BAT Buy | Jefferies & Company Inc. | |
| 17.09.26 | Unilever Outperform | Bernstein Research | |
| 17.09.26 | GSK Neutral | UBS AG | |
| 17.09.26 | Diageo Buy | Jefferies & Company Inc. | |
| 16.09.26 | Unilever Outperform | Bernstein Research | |
| 16.09.26 | Barclays Buy | UBS AG | |
| 16.09.26 | Diageo Hold | Deutsche Bank AG | |
| 16.09.26 | AstraZeneca Buy | UBS AG | |
| 16.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 16.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.09.26 | Rio Tinto Kaufen | DZ BANK | |
| 15.09.26 | GSK Hold | Deutsche Bank AG | |
| 15.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.09.26 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.09.26 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.09.26 | National Grid Outperform | Bernstein Research | |
| 15.09.26 | Barclays Overweight | JP Morgan Chase & Co. | |
| 14.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 14.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 14.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.09.26 | GSK Buy | Jefferies & Company Inc. | |
| 14.09.26 | Diageo Buy | Jefferies & Company Inc. | |
| 14.09.26 | BP Hold | Jefferies & Company Inc. | |
| 14.09.26 | Shell Buy | Jefferies & Company Inc. | |
| 14.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 11.09.26 | BAT Underperform | RBC Capital Markets | |
| 11.09.26 | Shell Buy | Goldman Sachs Group Inc. | |
| 11.09.26 | BP Buy | Goldman Sachs Group Inc. | |
| 10.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.09.26 | AstraZeneca Outperform | RBC Capital Markets | |
| 08.09.26 | GSK Sector Perform | RBC Capital Markets | |
| 08.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | BP Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.09.26 | GSK Underweight | Barclays Capital |